Evunzekibart Biosimilar - Research Grade

Human

TNFRSF9

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2804

Q07011

Blue ice

4-1BB (TNFRSF9/CD137) is a co-stimulatory receptor that boosts T-cell and NK-cell activity, a prominent target in immuno-oncology research. This recombinant anti-human TNFRSF9 monoclonal is an unconjugated, non-therapeutic analog of evunzekibart, supplied for research use only (RUO). It is manufactured to in vivo standards, carries low endotoxin, and is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Use it in functional assays, agonism and T-cell-co-stimulation studies, reproducible controls, and in vivo tumour-immunity models, with the lot-to-lot consistency needed for extended, heavy-usage research.

Detects human TNFRSF9

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks